Profile data is unavailable for this security.
About the company
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
- Revenue in EUR (TTM)7.92m
- Net income in EUR-833.12k
- Incorporated2000
- Employees39.00
- LocationNexstim OyjElimaenkatu 9 BHELSINKI 00510FinlandFIN
- Phone+358 92727170
- Fax+358 927271717
- Websitehttps://www.nexstim.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vo2 Cap Holding AB (publ) | 30.29m | -280.01k | 14.32m | 95.00 | -- | 0.7094 | 3.67 | 0.4729 | -0.0594 | -0.0594 | 6.49 | 4.03 | 0.7088 | -- | 7.97 | 3,340,253.00 | -0.6554 | -0.2564 | -0.8674 | -0.3839 | 35.84 | 23.36 | -0.9246 | -0.2409 | -- | 0.3201 | 0.1362 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| Immunovia AB (publ) | 77.93k | -10.22m | 14.60m | 10.00 | -- | 4.23 | -- | 187.29 | -1.30 | -1.30 | 0.0099 | 0.2162 | 0.0071 | -- | 14.39 | 80,454.55 | -93.50 | -41.33 | -133.56 | -44.24 | -6,702.03 | -7,553.76 | -13,120.79 | -20,879.29 | -- | 2.48 | 0.3064 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Neola Medical AB | 0.00 | -833.96k | 16.06m | 7.00 | -- | 2.47 | -- | -- | -0.1508 | -0.1508 | 0.00 | 1.05 | 0.00 | -- | -- | 0.00 | -12.63 | -17.04 | -13.59 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
| Arcoma AB | 15.44m | 1.11m | 17.82m | 31.00 | 15.99 | 3.58 | 10.13 | 1.15 | 0.9598 | 0.9598 | 13.30 | 4.28 | 2.02 | 3.96 | 9.19 | 5,654,936.00 | 14.61 | 1.12 | 24.24 | 2.01 | 37.85 | 37.66 | 7.22 | 0.7568 | 1.25 | 18.83 | 0.0407 | 0.00 | 30.36 | 6.41 | 34.81 | -- | 22.75 | -- |
| SpectraCure AB (publ) | 208.16k | -1.86m | 18.82m | 13.00 | -- | 1.81 | -- | 90.39 | -0.218 | -0.218 | 0.0243 | 1.21 | 0.0166 | -- | 24.63 | 157,600.00 | -14.82 | -12.75 | -15.91 | -13.62 | 442.39 | 195.30 | -895.85 | -494.40 | -- | -- | 0.0494 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
| Nanexa AB | 2.37m | -5.87m | 18.82m | 19.00 | -- | 2.46 | -- | 7.94 | -0.6938 | -0.6938 | 0.2484 | 0.6411 | 0.2108 | -3.83 | 2.99 | 1,416,316.00 | -52.24 | -40.77 | -70.59 | -48.77 | 118.77 | 77.27 | -247.79 | -532.26 | 1.92 | -- | 0.0174 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
| Bactiquant A/S | 1.20m | -1.94m | 22.21m | -- | -- | 24.26 | -- | 18.44 | -0.6558 | -0.6558 | 0.4064 | 0.2906 | 0.5101 | 2.94 | 5.06 | -- | -82.23 | -41.26 | -92.65 | -47.16 | -24.34 | 12.89 | -161.20 | -71.77 | 2.73 | -9.48 | 0.5326 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
| Scandinavian Medical Solutions A/S | 26.48m | 720.26k | 24.56m | 25.00 | 33.92 | 2.37 | 15.12 | 0.9273 | 0.1963 | 0.1963 | 7.22 | 2.81 | 1.38 | 1.89 | 11.35 | -- | 3.75 | -- | 6.15 | -- | 24.48 | -- | 2.72 | -- | 0.4307 | 5.54 | 0.3473 | -- | 72.98 | -- | 7.49 | -- | -- | -- |
| Nexstim Oyj | 7.92m | -833.12k | 25.03m | 39.00 | -- | 13.40 | -- | 3.16 | -0.1223 | -0.1223 | 1.19 | 0.2761 | 0.8196 | 0.2223 | 5.28 | 214,040.30 | -8.62 | -26.77 | -14.02 | -43.90 | 97.24 | 92.11 | -10.52 | -38.38 | 1.24 | -5.51 | 0.7716 | -- | -23.94 | 22.08 | -201.58 | -- | 19.51 | -- |
| INIFY Laboratories AB | 301.40k | -4.53m | 26.82m | 23.00 | -- | 4.16 | -- | 88.98 | -1.17 | -1.17 | 0.078 | 1.67 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Micropos Medical AB (publ) | 236.07k | -2.00m | 27.55m | 9.00 | -- | 15.29 | -- | 116.70 | -0.2463 | -0.2463 | 0.022 | 0.1341 | 0.0994 | 0.1315 | 1.20 | 335,122.50 | -84.10 | -64.24 | -111.33 | -82.27 | 79.96 | 114.76 | -845.91 | -767.57 | 3.18 | -- | 0.0184 | -- | 50.23 | 5.94 | -26.57 | -- | -- | -- |
| Ortoma AB | 3.81m | -2.71m | 28.19m | 7.00 | -- | 1.93 | -- | 7.41 | -0.8112 | -0.8112 | 1.24 | 4.67 | 0.2294 | 1.01 | 4.49 | 6,173,962.00 | -16.34 | -10.45 | -17.53 | -11.64 | 86.83 | 339.86 | -71.22 | -175.52 | 3.04 | -- | 0.00 | -- | -- | -- | -38.87 | -- | 14.14 | -- |
| Acarix AB | 550.95k | -6.25m | 28.28m | 9.00 | -- | 4.74 | -- | 51.33 | -0.1168 | -0.1168 | 0.0095 | 0.0697 | 0.0894 | 0.1172 | 2.47 | -- | -101.38 | -66.93 | -123.43 | -77.12 | 88.27 | 79.42 | -1,133.87 | -1,483.68 | 5.21 | -328.98 | 0.00 | -- | 7.20 | 43.55 | -1.11 | -- | -- | -- |
| Karolinska Development AB | 167.57k | -497.42k | 28.83m | 8.00 | -- | 0.2683 | -- | 172.07 | -0.0209 | -0.0209 | 0.007 | 4.56 | 0.0015 | -- | 1.38 | 237,875.00 | -0.4536 | 3.37 | -0.4578 | 3.83 | -- | -- | -296.85 | 1,466.36 | -- | -- | 0.0021 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
| Boule Diagnostics AB | 50.41m | 1.87m | 30.30m | 230.00 | 16.50 | 0.6934 | 7.25 | 0.601 | 0.5368 | 0.5368 | 14.45 | 12.78 | 0.724 | 4.19 | 3.69 | 2,511,092.00 | 2.68 | 1.67 | 3.71 | 2.40 | 43.86 | 43.50 | 3.70 | 2.04 | 0.9268 | 4.72 | 0.2698 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Q linea AB | 413.41k | -19.78m | 30.33m | 99.00 | -- | 5.06 | -- | 73.37 | -2.06 | -2.06 | 0.0428 | 0.5813 | 0.0277 | 0.1707 | 11.86 | 36,968.50 | -132.70 | -59.66 | -356.93 | -66.14 | -56.25 | -378.58 | -4,783.96 | -4,046.97 | 0.6999 | -- | 0.4555 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
Data as of Sep 23 2024. Currency figures normalised to Nexstim Oyj's reporting currency: Euro EUR
0.75%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Andbank Wealth Management SGIIC SAUas of 30 Jun 2024 | 35.58k | 0.53% |
| Evli Fund Management Co. Ltd.as of 30 Aug 2024 | 14.93k | 0.22% |
Data from 30 Jun 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.
